[INSERT TABLE 1]
Inferential Analysis
The clinical complications following pregnancy tissue expulsion were
classified into different groups, and the data has been put together in
Table-2. Mild to moderate post-abortion hemorrhage was treated with
misoprostol accompanied by methylergometrine, and this group constituted
the majority of the patients (83.3%), the only exception to this being
two patients who reported acute painful misoprostol bleeding (more
painful than severe menstrual cramps). Whereas, the groups that received
misoprostol plus oxytocin and misoprostol alone complained of mild to
severe pains, and constituted 80% and 73.3% of the study sample,
respectively. Further, with regards to the distribution of bleeding
onset, no statistical significance could be established (P=0.627)
(Table2).
As for pain severity, the VAS score was compared in the three groups’
post-abortion and after medication misoprostol intake. The outcome for
the three groups that comprised of those given misoprostol plus
oxytocin, misoprostol plus methylergonovine and misoprostol alone, the
median and first, second and third quantiles (percentiles of
25th, 50th, and
75th) were obtained [3 (interquartile range (IQR) of
2.75-5.25), 2 (IQR: 1.75-4) and 4.5 (IQR: 2.75-6)] with a P-value of
0.014, respectively (Figure 2). Notably, the median score of VAS in the
group that received a compound of misoprostol plus methylergonovine was
less than that of the group treated by misoprostol alone, with P=0.011.
On the other hand, there was no evidence of a remarkable statistical
significance in the median VAS score between those patients who received
misoprostol plus methylergonovine and misoprostol plus oxytocin. Similar
observations were reported in the group treated with combined therapy of
oxytocin plus misoprostol and misoprostol alone, with
P>0.05 (Table 2)